Alteplase beyond three hours in ischemic stroke: do we know enough?
Jawaid
Ali
A
Fitch
Olivia
O
Qureshi
Salah
S
Wilson
Andrew M
AM
Schulz
Paul E
PE
D000818:Animals; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D020127:Recovery of Function; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage* / Q000009:adverse effects*; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator